Eieling Technology, which develops medical ultrasound solutions to detect conditions such as liver fibrosis and fatty liver, has secured “several hundred million” HKD in its latest funding round, without disclosing the investors.
Founded in 2018, the Hong Kong-based firm was previously a project incubated by the Department of Biomedical Engineering of the Hong Kong Polytechnic University. Eieling aims to develop a portable ultrasound device for diagnosis and screening of liver fibrosis.
With subsidiaries in Shanghai and Shenzhen, the firm has received funding from the Hong Kong Polytechnic University, as well as Hong Kong Science and Technology Parks Corporation (HKSTP), a government body set up to foster the city’s innovation and technology ecosystem.
CHINA DEAL MONITOR
DealStreetAsia has also compiled a table listing all prominent venture capital transactions in Greater China from May 12 – 18, 2025.
